FdaApplication
BLA 103000
Identifiers
- fda_app_no: BLA103000
Properties
| Property | Value |
|---|---|
| applicant_name | AbbVie Inc. |
| application_type | BLA |
| approval_date | 1991-12-09 |
Revenue by product
BOTOX
| Period | Revenue |
|---|---|
| Q2 2026 | $1.0B |
| Q1 2026 | $1.0B |
| Q4 2025 | $990.0M |
| Q3 2025 | $985.0M |
| Q2 2025 | $928.0M |
| Q1 2025 | $866.0M |
| Q4 2024 | $873.0M |
| Q3 2024 | $848.0M |
| Q2 2024 | $814.0M |
| Q1 2024 | $748.0M |
| Q4 2023 | $776.0M |
| Q3 2023 | $748.0M |
| Q2 2023 | $748.0M |
| Q1 2023 | $719.0M |
| Q4 2022 | $728.0M |
| Q3 2022 | $699.0M |
| Q2 2022 | $678.0M |
| Q1 2022 | $614.0M |
| Q4 2021 | $671.0M |
| Q3 2021 | $645.0M |
| Q2 2021 | $603.0M |
| Q1 2021 | $532.0M |
| Q4 2020 | $567.0M |
| Q3 2020 | $523.0M |
| Q2 2020 | $297.0M |
| Q1 2020 | $0.0M |
| Q4 2019 | $0.0M |
| Q3 2019 | $0.0M |
| Q2 2019 | $0.0M |
Revenue as this company reported it for this product. A combination product's amount is stated once, for the product, and never divided across its ingredients. A fourth quarter is the reported full year less nine months, since no filing states one.
BOTOX COSMETIC
| Period | Revenue |
|---|---|
| Q2 2026 | $728.0M |
| Q1 2026 | $668.0M |
| Q4 2025 | $717.0M |
| Q3 2025 | $637.0M |
| Q2 2025 | $692.0M |
| Q1 2025 | $556.0M |
| Q4 2024 | $687.0M |
| Q3 2024 | $671.0M |
| Q2 2024 | $729.0M |
| Q1 2024 | $633.0M |
| Q4 2023 | $718.0M |
| Q3 2023 | $620.0M |
| Q2 2023 | $685.0M |
| Q1 2023 | $659.0M |
| Q4 2022 | $642.0M |
| Q3 2022 | $637.0M |
| Q2 2022 | $695.0M |
| Q1 2022 | $641.0M |
| Q4 2021 | $626.0M |
| Q3 2021 | $545.0M |
| Q2 2021 | $584.0M |
| Q1 2021 | $477.0M |
| Q4 2020 | $493.0M |
| Q3 2020 | $393.0M |
| Q2 2020 | $226.0M |
| Q1 2020 | $0.0M |
| Q4 2019 | $0.0M |
| Q3 2019 | $0.0M |
| Q2 2019 | $0.0M |
Revenue as this company reported it for this product. A combination product's amount is stated once, for the product, and never divided across its ingredients. A fourth quarter is the reported full year less nine months, since no filing states one.
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BOTOX COSMETIC | OnabotulinumtoxinA | 100UNITS | VIAL;SINGLE-USE |
| BOTOX COSMETIC | OnabotulinumtoxinA | 50UNITS | VIAL;SINGLE-USE |
| BOTOX | OnabotulinumtoxinA | 50UNITS | VIAL;SINGLE-USE |
| BOTOX | OnabotulinumtoxinA | 200UNITS | VIAL;SINGLE-USE |
| BOTOX | OnabotulinumtoxinA | 100UNITS | VIAL;SINGLE-USE |
5 products